Together, Nrf2 and Gal-3 highlight complementary aspects of IBD pathogenesis—redox imbalance versus lectin-mediated inflammation—and combined assessment may ultimately offer improved disease stratification and prediction of complications. This evidence concerns the gene NFE2L2 and inflammatory bowel disease.